ArticleCancer science2019

SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met.

Mengya Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.